Giving the respiratory syncytial virus (RSV) vaccine to pregnant women provides 81.3% protection to newborn infants, ...

Respiratory syncytial virus (RSV) is a common virus that can cause severe respiratory illness in infants and young children, ...

Maternal RSV shots given 2+ weeks before birth cut infant hospitalization by 80%, providing a powerful defense against ...

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for infants on life support with severe bronchiolitis—a seasonal viral illness ...

A UK study finds the RSV vaccine in pregnancy can reduce infant hospitalisation risk by up to 85%, especially when given in ...

Bronchiolitis - most often caused by RSV - is the leading reason why babies are admitted to hospital in the UK during winter. It typically affects babies under one year old and can be especially ...

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug has been approved at the European level to protect infants in their first ...

As with any medicine, the MHRA will keep the safety and effectiveness of Enflonsia under close review. The Medicines and Healthcare products ...

The largest real-world study of its kind, presented today at ESCMID Global 2026, shows that maternal vaccination against ...